Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer: A meta‐analysis

BACKGROUND: To investigate the efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer (NSCLC) through pooling of open published data. METHODS: The electronic databases of Medline (1960–2021.5), C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Liu, Zhibao, Wu, Yuanyuan, Li, Huarui, Sun, Zhen, Han, Chenggang, Zhang, Xiaoling, Zhang, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563161/
https://www.ncbi.nlm.nih.gov/pubmed/34622571
http://dx.doi.org/10.1111/1759-7714.14131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563161/
https://www.ncbi.nlm.nih.gov/pubmed/34622571
http://dx.doi.org/10.1111/1759-7714.14131

Ejemplares similares